Delivery Order SPE2DB20D7066-SPE2DB25FC4KJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,189.58 to AmerisourceBergen Drug Corp for Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nitrofurantoin is a broad-spectrum antibiotic commonly used to treat urinary tract infections,...
- This delivery order, valued at $6,938.00, awards AmerisourceBergen Drug Corp the supply of Nitrofurantoin 25 mg/5 ml suspension in 230 ml quantities under a firm fixed price arrangement. The contract was competitively awarded without set-aside restrictions and is scheduled for completion by July 21, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's broader...
- The Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,431.42 for Nitrofurantoin 25 mg/5 mL suspension (230 mL) on August 5, 2025, with completion expected by August 6, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension with a ceiling value of $3,033.72. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with a ceiling value of $6,907.65. This contract represents a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,539.37 firm fixed price delivery order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL suspension medication. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, valued at $3,014.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nitrofurantoin 25 mg/5 ml suspension in 240 ml bottles. The $15,154.76 firm-fixed-price delivery order contract has a performance period through September 18, 2024 and is not set aside for any specific business type. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml Suspension, a pharmaceutical product, with a ceiling value of $18,234.82. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,018.27, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4KJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.72 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin 25 mg/5 mL suspension in a 230 mL quantity. This contract was competitively awarded without a set-aside designation and operates under firm fixed price terms, with an ultimate completion date of August 21, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply medications and medical supplies to military healthcare programs and federal customers including the Defense Health Agency and U.S. Coast Guard. Nitrofurantoin is an antibiotic commonly used in military and federal healthcare settings, and this delivery order represents a routine fulfillment under the company's established relationship with DLA for pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/20/25 |